Comparing Levetiracetam and phenobarbital as first-line treatment for neonatal seizures
Phase 3
- Conditions
- eonatal seizure.Convulsions of newborn
- Registration Number
- IRCT20220410054471N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
Neonates with seizure manifestations
Exclusion Criteria
Renal impairment
Lack of consent
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Seizure control. Timepoint: 48 hours. Method of measurement: clinical.;Seizure recurrence control. Timepoint: 48 hours. Method of measurement: Clinical.
- Secondary Outcome Measures
Name Time Method